<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Inovio Pharmaceuticals Reports Positive Interim Results for COVID-19 Vaccine Clinical Trials
Image Overlay - Inovio Pharmaceuticals Reports Positive Interim Results for COVID-19 Vaccine Clinical Trials

Inovio Pharmaceuticals Reports Positive Interim Results for COVID-19 Vaccine Clinical Trials

Inovio Pharmaceuticals Reports Positive Interim Results for COVID-19 Vaccine Clinical Trials

Inovio Pharmaceuticals recruited 40 healthy adults aged 18-50 to take part in their phase I trial of vaccine candidate INO-4800. Participants were given two doses of the vaccine 4 weeks apart - 94% of total participants experienced overall immunological response rates and no adverse events by week 8. The trial will be expanded to include older adults and move to phase II/III launching over the coming months. With 21 strategically located global depots, over 20 years of experience, and a delivery rate of 99.9%, Yourway is the perfect partner to push clinical trials forward.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Precision in Pharma Supply Chain Summit Boston

November 16-17, 2026
Boston, MA

SCOPE Supply Chain & Logistics Leadership Summit

March 1-4, 2027
Orlando, FL

Media

Articles

Promises Start Partnerships. Performance Builds Them.

Open chat
Come chat with us!
Hello! How can I help you?